MCID: END042
MIFTS: 78

Endometrial Carcinoma malady

Cancer diseases category

Summaries for Endometrial Carcinoma

About this section
Sources:
8Disease Ontology, 63Wikipedia, 46OMIM, 32MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
Wikipedia:63 Endometrial cancer is any of several types of malignancies that arise from the endometrium, or lining,... more...

MalaCards: Endometrial Carcinoma, also known as endometrial cancer, is related to adenocarcinoma and papillary carcinoma. An important gene associated with Endometrial Carcinoma is MSH3 (mutS homolog 3), and among its related pathways are Pathways in cancer and Endometrial cancer. The compounds progesterone and retinoic acid have been mentioned in the context of this disorder. Affiliated tissues include the tissue lining the uterus, uterus and lymph node, and related mouse phenotypes are cellular and tumorigenesis.

Disease Ontology:8 A endometrial cancer that is located in the tissue lining the uterus.

Description from OMIM:46 608089

Aliases & Classifications for Endometrial Carcinoma

About this section
Sources:
8Disease Ontology, 46OMIM, 44Novoseek, 60UMLS, 9diseasecard, 42NIH Rare Diseases, 22GTR, 10DISEASES, 34MeSH, 56SNOMED-CT, 39NCIt, 25ICD10
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Cancer diseases


Aliases & Descriptions:

endometrial carcinoma 8 46 44 60
endometrial cancer 9 42 22 46 10 44
endometrioid carcinoma of female reproductive system 8
carcinoma of the endometrium 8
carcinoma of endometrium 8
carcinoma, endometrioid 60
endometrioid carcinoma 8
carcinoma endometrioid 44


External Ids:

Disease Ontology8 DOID:2871
MeSH34 D018269
OMIM46 608089
NCIt39 C3769
ICD1025 C54.1

Related Diseases for Endometrial Carcinoma

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases in the Endometrial Carcinoma family:

Endometrial Cancer, Familial

Diseases related to Endometrial Carcinoma via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 256)
idRelated DiseaseScoreTop Affiliating Genes
1adenocarcinoma30.8IFI27, CTNNB1, ARSH, PIK3CA, MLH1, MKI67
2papillary carcinoma30.7ESR1, PGR, CDH1, MKI67, IFI27
3endometriosis30.6ARSH, HOXA10, PGR, PTEN, ESR1
4transitional cell carcinoma30.4IFI27, MLH1, MKI67, CDH1
5lynch syndrome30.4MLH1, MLH3, KRAS, MSH3
6ovarian cancer30.3KLK4, IFI27, CTNNB1, PIK3CA, MLH1, CDH1
7colorectal cancer30.3IFI27, CTNNB1, PTEN, MSH3, KRAS, CDH1
8breast cancer30.3IFI27, CTNNB1, PIK3CA, CDH1, PGR, KRAS
9cervical adenocarcinoma30.3IFI27, CDKN2A, PGR, ESR1
10retinoblastoma30.2IFI27, PIK3CA, MKI67, CDKN2A, KRAS, ESR1
11cervical cancer30.2IFI27, PIK3CA, MLH1, CDKN2A, KRAS
12squamous cell carcinoma30.1MKI67, CDH1, MMP26
13pancreatic cancer30.1IFI27, CTNNB1, ARSH, PIK3CA, MLH1, ANG
14endometrial carcinoma, somatic30.1CDH1, PTEN
15myoma30.1PGR, ESR1
16adenocarcinoma in situ30.1CDKN2A
17leiomyoma30.1ESR1, PGR, MKI67
18infertility30.1ESR1, HOXA10
19pancreatitis30.1KRAS
20cystadenoma30.0KRAS
21colon cancer29.9CTNNB1, PIK3CA, MLH1, CDH1, KRAS, TDGF1P3
22lung cancer29.9PIK3CA, CDKN2A, CDH1, KRAS, PTEN
23melanoma29.9IFI27, CTNNB1, PIK3CA, MLH1, ANG, MKI67
24sarcoma29.9MLH1, MKI67, KRAS
25tuberous sclerosis29.9PTEN, PIK3CA, IFI27
26inflammatory breast carcinoma29.9ESR1, PGR, CDH1
27papilloma29.9CDKN2A, IFI27
28prolactinoma29.9ESR1
29prostate cancer29.9IFI27, CTNNB1, MKI67, CDH1, MMP26, PTEN
30endometrial stromal sarcoma29.9PGR, ESR1
31thyroid cancer29.9PTEN, CDH1, PIK3CA, IFI27
32small cell carcinoma10.7
33cervicitis10.6
34neuroendocrine carcinoma10.5
35lymph node cancer10.5
36endometrial adenocarcinoma10.5
37vascular cancer10.4
38verrucous carcinoma10.4
39large cell carcinoma10.4
40peritonitis10.4
41vaginitis10.4
42in situ carcinoma10.3
43ovarian brenner tumor10.3
44lymphoepithelioma-like carcinoma10.3
45endometrial transitional cell carcinoma10.3
46obesity10.3
47ovarian endometriosis10.3
48ovarian endometrioid neoplasm10.3
49uterine inversion10.2
50bone carcinoma10.2

Graphical network of the top 20 diseases related to Endometrial Carcinoma:



Diseases related to endometrial carcinoma

Clinical Features for Endometrial Carcinoma

About this section
Sources:
46OMIM
See all sources

Clinical features from OMIM:

608089

Drugs & Therapeutics for Endometrial Carcinoma

About this section
Sources:
5CenterWatch, 41NIH Clinical Center, 6ClinicalTrials, 60UMLS, 40NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Endometrial Carcinoma

Drug clinical trials:

Search ClinicalTrials for Endometrial Carcinoma

Search NIH Clinical Center for Endometrial Carcinoma

Search CenterWatch for Endometrial Carcinoma

Genetic Tests for Endometrial Carcinoma

About this section
Sources:
22GTR
See all sources

Genetic tests related to Endometrial Carcinoma:

id Genetic test Affiliating Genes
1 Endometrial Carcinoma22

Anatomical Context for Endometrial Carcinoma

About this section
Sources:
32MalaCards, 14FMA
See all sources

MalaCards organs/tissues related to Endometrial Carcinoma:

32
Uterus, Lymph node, Breast, Endothelial, Ovary, Cervix, Colon, Testes, T cells, Bone, Testis, Pituitary, Lung, Small intestine, Retina, Brain, Tongue

FMA organs/tissues related to Endometrial Carcinoma:

14
The tissue lining the uterus

Animal Models for Endometrial Carcinoma or affiliated genes

About this section
Sources:
36MGI
See all sources

MGI Mouse Phenotypes related to Endometrial Carcinoma:

36 (show all 14)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000538412.0CTNNB1, PIK3CA, MLH1, CDKN2A, CDH1, PGR
2MP:000200612.0ESR1, CTNNB1, PIK3CA, MLH1, CDKN2A, CDH1
3MP:001076811.8MLH1, PIK3CA, CTNNB1, KLK4, CDKN2A, CDH1
4MP:000538911.7CTNNB1, PIK3CA, MLH1, MLH3, CDKN2A, CDH1
5MP:000537811.7KLK4, CTNNB1, PIK3CA, CDKN2A, CDH1, HOXA10
6MP:000538111.7CTNNB1, MLH1, CDKN2A, CDH1, HOXA10, KRAS
7MP:001077111.6CTNNB1, PIK3CA, CDKN2A, CDH1, KRAS, MSH3
8MP:000537911.5PIK3CA, MLH1, MLH3, CDKN2A, HOXA10, KRAS
9MP:000537611.5KLK4, PIK3CA, PGR, MSH3, ESRRA, ESR1
10MP:000538711.3CTNNB1, PIK3CA, CDKN2A, CDH1, PGR, KRAS
11MP:000539010.9ESRRA, PGR, HOXA10
12MP:000536910.8CDKN2A, ESR1
13MP:000538010.8PGR
14MP:000537110.7HOXA10

Publications for Endometrial Carcinoma

About this section
Sources:
50PubMed
See all sources

Articles related to Endometrial Carcinoma:

(show top 50)    (show all 1342)
idTitleAuthorsYear
1
Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. (24004646)
2013
2
Prognostic significance and diagnostic value of PTEN and p53 expression in endometrial carcinoma. A retrospective clinicopathological and immunohistochemical study. (23613406)
2013
3
Effects of expression of exogenous cyclin G1 on proliferation of human endometrial carcinoma cells. (23589924)
2013
4
Endometrial metaplasia: correlation of histological and cytological specimens obtained from 103 cases undergoing hysterectomy for endometrial carcinoma. (23517058)
2013
5
A comparison of extraperitoneal versus transperitoneal laparoscopic or robotic para-aortic lymphadenectomy for staging of endometrial carcinoma. (24361579)
2013
6
Tumor angiogenesis, macrophages and mast cell microdensities in endometrioid endometrial carcinoma. (24137338)
2013
7
hMLH1 promoter hypermethylation and MSI status in human endometrial carcinomas with and without metastases. (22552371)
2012
8
Primary endometrial small cell carcinoma. (22185556)
2012
9
Aberrant expression of the von Hippel-Lindau gene in human endometrial hyperplasia and endometrial carcinoma. (21436690)
2011
10
Significant variation in the assessment of cervical involvement in endometrial carcinoma: an interobserver variation study. (21263250)
2011
11
EphrinA1 stimulates cell attachment and inhibits cell aggregation through the EphA receptor pathway in human endometrial carcinoma-derived Ishikawa cells. (21349856)
2011
12
Importance of office hysteroscopy screening to diagnose endometrial carcinoma in menopausal women. (21797122)
2011
13
Identification of estrogen response element in the aquaporin-2 gene that mediates estrogen-induced cell migration and invasion in human endometrial carcinoma. (21715543)
2011
14
The microRNA-200 family is upregulated in endometrial carcinoma. (21897839)
2011
15
Total laparoscopic hysterectomy versus total abdominal hysterectomy with bilateral salpingo-oophorectomy for endometrial carcinoma: a randomised controlled trial with 5-year follow-up. (22081769)
2011
16
Primary follicular lymphoma of the fallopian tube found incidentally in a patient treated for endometrial carcinoma: a case report. (20584306)
2010
17
The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor. (20060158)
2010
18
Clinical significance of regulatory T cells and CD8+ effector populations in patients with human endometrial carcinoma. (20734397)
2010
19
Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN]. (19563062)
2009
20
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. (19261849)
2009
21
Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium. (19435786)
2009
22
Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases. (19623034)
2009
23
Analysis of stage IVB endometrial carcinoma patients with distant metastasis: a review of prognoses in 55 patients. (19705246)
2009
24
Primary endometrial squamous cell carcinoma. (18236059)
2008
25
Wilms' tumor gene 1 (WT1) in endometrial carcinoma. (18929401)
2008
26
Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma. (18369088)
2008
27
Endometrial lymphoepitheliomalike carcinoma: absence of Epstein-Barr virus genomes. (17362326)
2007
28
Characterization of EN-1078D, a poorly differentiated human endometrial carcinoma cell line: a novel tool to study endometrial invasion in vitro. (17894888)
2007
29
Stromal cell-derived factor 1alpha stimulates human endometrial carcinoma cell growth through the activation of both extracellular signal-regulated kinase 1/2 and Akt. (16884765)
2006
30
Anti-tumor effects of herbal medicines on endometrial carcinomas via estrogen receptor-alpha-related mechanism. (16596174)
2006
31
Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients. (16152605)
2006
32
Uterine inversion associated with endometrial carcinoma: a case report. (16147720)
2005
33
Expression and clinical significance of KISS-1 and GPR54 mRNA in endometrial carcinoma]. (15949424)
2005
34
Expression of the cell-cycle regulatory proteins (cyclins D1 and E) in endometrial carcinomas: correlations with hormone receptor status, proliferating indices, tumor suppressor gene products (p53, pRb), and clinicopathological parameters. (15597850)
2004
35
Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray. (15297187)
2004
36
Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. (12657124)
2003
37
Unsuspected uterine carcinosarcoma (heterologous) diagnosed following conservative therapies with medroxyprogesterone acetate for presumed early-stage endometrial carcinoma. (12069197)
2002
38
Hereditary and somatic DNA mismatch repair gene mutations in sporadic endometrial carcinoma. (11474654)
2001
39
Methylation of hMLH1 in a population-based series of endometrial carcinomas. (10999752)
2000
40
Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma. (10053103)
1999
41
Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study. (10334522)
1999
42
Abnormal expression of cripto and p53 protein in endometrial carcinoma and its precursor lesions. (9641241)
1998
43
BAX somatic frameshift mutations in endometrioid adenocarcinomas of the endometrium: evidence for a tumor progression role in endometrial carcinomas with microsatellite instability. (9840618)
1998
44
Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma. (9599835)
1998
45
Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies. (7856758)
1995
46
Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas]. (8371006)
1993
47
Expression of c-myc, epidermal growth factor receptor and c-erbB-2 in human endometrial carcinoma and cervical adenocarcinoma. (1687493)
1991
48
Relation between the levels of estrogen receptor and progesterone receptor and clinicopathological status in human endometrial carcinomas]. (1774041)
1991
49
Analysis of oncogene alterations in human endometrial carcinoma: prevalence of ras mutations. (2064724)
1991
50
Benign senile pyometra, endometrial cholesterol granulomas and adenosquamous carcinoma. (3863595)
1985

Genetic Variations for Endometrial Carcinoma

About this section
Sources:
62UniProtKB/Swiss-Prot
See all sources

Genetic disease variations for Endometrial Carcinoma:

62
id Symbol AA change Variation ID SNP ID
1PTENp.His123TyrVAR_026260

Expression for genes affiliated with Endometrial Carcinoma

About this section
Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Endometrial Carcinoma

Search GEO for disease gene expression data for Endometrial Carcinoma.

Pathways for genes affiliated with Endometrial Carcinoma

About this section
Sources:
29KEGG, 12EMD Millipore, 37NCBI BioSystems Database, 53Reactome, 51QIAGEN
See all sources

Pathways related to Endometrial Carcinoma according to GeneCards/GeneDecks:

(show all 24)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
111.5CTNNB1, PIK3CA, MLH1, CDKN2A, CDH1, KRAS
2
Hide members
11.4PTEN, CTNNB1, PIK3CA, MLH1, CDH1, KRAS
3
Hide members
11.2CTNNB1, PIK3CA, CDH1, KRAS, PTEN, ESR1
411.1CTNNB1, CDH1, KRAS, PTEN, ESR1
5
Hide members
11.1PIK3CA, PGR, KRAS, PTEN, ESR1
611.1ESR1, PTEN, KRAS, PIK3CA, CTNNB1
7
Development Endothelin-1/EDNRA signaling
Hide members
11.1CTNNB1, PIK3CA, KRAS, PTEN, ESR1
811.0ESR1, KRAS, PIK3CA, CTNNB1
911.0PTEN, KRAS, CDKN2A, PIK3CA
1011.0KRAS, CDKN2A, PIK3CA, CTNNB1
11
Hide members
10.9MLH1, MLH3, MSH3
1210.9CTNNB1, CDH1, KRAS
13
Transcription Androgen Receptor nuclear signaling
Hide members
10.9CTNNB1, PIK3CA, PTEN
1410.9CTNNB1, PIK3CA, CDH1
15
Hide members
10.9CDH1, PIK3CA, CTNNB1
1610.9CDH1, PIK3CA, CTNNB1
1710.9CTNNB1, PIK3CA, CDH1
1810.9CTNNB1, CDKN2A, PTEN
19
Hide members
10.9ESR1, ESRRA, PGR
20
Hide members
10.9KRAS, CDKN2A, PIK3CA
2110.7CDH1, CTNNB1
2210.7CTNNB1, CDH1
2310.6MSH3
24
Hide members
10.6KRAS

Compounds for genes affiliated with Endometrial Carcinoma

About this section
Sources:
44Novoseek, 59Tocris Bioscience, 28IUPHAR, 11DrugBank, 24HMDB, 49PharmGKB, 2BitterDB
See all sources

Compounds related to Endometrial Carcinoma according to GeneCards/GeneDecks:

(show top 50)    (show all 138)
idCompoundScoreTop Affiliating Genes
1progesterone44 59 28 11 2416.8MKI67, CDKN2A, CDH1, HOXA10, PGR, PTEN
2retinoic acid44 2413.7MKI67, CDKN2A, CDH1, MMP26, KRAS, PTEN
3testosterone44 59 11 2415.4PIK3CA, ESRRA, ESR1, PTEN, ARSH, PGR
4vegf4412.4MLH1, PIK3CA, CTNNB1, IFI27, MKI67, ESR1
5doxorubicin44 49 1114.3PIK3CA, ESR1, PTEN, MSH3, PGR, CDH1
6tyrosine4412.2PTEN, KRAS, ANG, HOXA10, CDH1, MKI67
7paclitaxel44 49 1114.2IFI27, CTNNB1, PIK3CA, PTEN, ESR1, MLH1
85fluorouracil4412.2CDKN2A, CDH1, PGR, KRAS, PTEN, ESR1
9tamoxifen44 49 28 1115.2ESRRA, PIK3CA, CTNNB1, MKI67, CDH1, PTEN
10paraffin4412.2ESR1, KRAS, PGR, CDH1, CDKN2A, MKI67
11cisplatin44 49 59 1115.2MSH3, CDH1, CDKN2A, IFI27, MKI67, MLH1
12genistein44 28 59 2 11 2417.0PTEN, ESRRA, ESR1, PGR, CDH1, IFI27
13arginine4412.0IFI27, PTEN, ARSH, CDH1, PIK3CA, MLH1
14steroid4411.9IFI27, ARSH, PIK3CA, MKI67, CDKN2A, HOXA10
15crcs4411.8CDH1, KRAS, PTEN, PIK3CA, CTNNB1, MLH1
16gefitinib44 49 1113.8KRAS, IFI27, CTNNB1, ESR1, PTEN, PIK3CA
175-aza-2deoxycytidine4411.8PTEN, ESR1, PGR, CDH1, CDKN2A, MLH1
18agar4411.8CDKN2A, PIK3CA, CDH1, PGR, PTEN, TDGF1P3
19fatty acid4411.7PTEN, MLH1, CTNNB1, IFI27, KRAS, ESRRA
20ly2940024411.7PTEN, PIK3CA, KRAS, CDH1, CTNNB1, IFI27
21trastuzumab44 49 1113.6IFI27, PTEN, PGR, PIK3CA, CTNNB1, ESR1
22estradiol44 11 2413.6ARSH, PTEN, MMP26, HOXA10, MKI67, PGR
23p0024411.6IFI27, CTNNB1, CDH1, KRAS, MKI67, MLH1
24mg 13244 5912.6IFI27, CTNNB1, CDH1, PTEN, ESR1, CDKN2A
25indole-3-carbinol4411.5IFI27, CTNNB1, CDH1, PTEN, ESR1
26diethylstilbestrol44 28 1113.5PGR, ESRRA, ESR1, PTEN, HOXA10
27vitamin d4411.5PTEN, ESR1, IFI27, CTNNB1, CDH1, KRAS
28irinotecan44 49 1113.5KRAS, CDH1, CDKN2A, MLH1, MKI67
29thymidylate4411.4CDH1, IFI27, MLH1, MKI67, CDKN2A
30docetaxel44 49 59 1114.4PIK3CA, CDKN2A, CDH1, ESR1, PGR
31sodium bisulfite4411.4CDKN2A, CDH1, MLH1, CTNNB1
32rapamycin4411.3PTEN, KRAS, CDH1, PIK3CA, CTNNB1, IFI27
33chi 24411.3MLH1, IFI27, MKI67, CDH1
34danazol44 11 2413.3ARSH, CDH1, PGR, ESR1
35o6-methylguanine4411.3MLH1, KRAS, CDKN2A, CDH1
36p000014411.3MLH1, CDH1, CDKN2A, MKI67
37steroidal4411.3PGR, IFI27, ESR1, ARSH
38bromodeoxyuridine4411.3CTNNB1, MLH1, MKI67, PIK3CA, IFI27
39sulindac44 1112.2IFI27, CTNNB1, MLH1, CDH1
40erlotinib44 49 1113.2CDH1, PIK3CA, KRAS, PTEN
41oxygen44 2412.2KRAS, IFI27, CDKN2A, MKI67, PTEN, ARSH
42estrogen4411.2HOXA10, ARSH
43quercetin44 59 11 2414.1PTEN, PIK3CA, CTNNB1, IFI27, ARSH
44folate4411.1MLH1, CDKN2A, CDH1, PGR, MKI67
4517beta-hydroxysteroid4411.0ARSH, MKI67, PGR, ESR1
46dihydrotestosterone44 28 11 2414.0ESR1, PGR, ARSH
47resveratrol44 59 11 2413.9PGR
48butyrate4410.9ARSH
49progestins4410.9ARSH, MKI67, ESR1, PGR
50cycloheximide4410.8HOXA10

GO Terms for genes affiliated with Endometrial Carcinoma

About this section
Sources:
16Gene Ontology
See all sources

Cellular components related to Endometrial Carcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1nucleusGO:00563411.7CTNNB1, MLH1, MLH3, ANG, MKI67, CDKN2A
2internal side of plasma membraneGO:00989810.9PTEN, CDH1, CTNNB1
3chiasmaGO:00571210.9MLH3, MLH1
4MutLbeta complexGO:03239010.8MLH3, MLH1
5mismatch repair complexGO:03230010.7MLH1, MLH3
6Schmidt-Lanterman incisureGO:04322010.7PTEN, CDH1
7catenin complexGO:01634210.6CDH1, CTNNB1

Biological processes related to Endometrial Carcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1mismatch repairGO:00629810.9MSH3, MLH3, MLH1
2reciprocal meiotic recombinationGO:00713110.9MSH3, MLH3, MLH1
3positive regulation of nitric-oxide synthase activityGO:05100010.7ESR1, KRAS
4regulation of protein localization to cell surfaceGO:200000810.6CTNNB1, CDH1
5cellular response to indole-3-methanolGO:07168110.4CTNNB1, CDH1

Molecular functions related to Endometrial Carcinoma according to GeneCards/GeneDecks:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1protein bindingGO:00551512.6ESR1, CTNNB1, PIK3CA, MLH1, MLH3, ANG
2enzyme bindingGO:01989911.3CTNNB1, PGR, MSH3, PTEN, ESR1
3steroid bindingGO:00549611.0ESR1, ESRRA, PGR
4steroid hormone receptor activityGO:00370710.9PGR, ESRRA, ESR1
5guanine/thymine mispair bindingGO:03213710.8MSH3, MLH1
6single-stranded DNA bindingGO:00369710.8MLH1, MLH3, MSH3
7centromeric DNA bindingGO:01923710.7MSH3, MLH3
8mismatched DNA bindingGO:03098310.7MSH3, MLH3
9MutSalpha complex bindingGO:03240710.4MLH3, MLH1

Products for genes affiliated with Endometrial Carcinoma

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Endometrial Carcinoma

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
50PubMed
51QIAGEN
57SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet